http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1272213-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B55-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
filingDate 1983-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1990-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fd330d5cd458152d2de6d39dc1c60ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_539ac6f5b176a88ac63d733dfabdc1a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447ac5b97c8dc69b7d7a80a75a073335
publicationDate 1990-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1272213-A
titleOfInvention Process for inverting the configuration of optically active compounds, and optically active intermediates produced in this process
abstract ABSTRACT OF THE INVENTION The invention relates to a process for inverting the configuration at the optically active carbon atom (*) in compounds of the formula I (I) in which A denotes a carbocyclic or heterocyclic aromatic radical and R denotes an aliphatic, cycloaliphatic or araliphatic hydrocarbon radical, by formylation, treating the resulting compounds with a strong acid or an acid halide and cleaving the oxazolinium derivatives thus obtained, by acid or alkaline hydrolysis, if appropriate via the stage of the N-formyl compound, and to oxazolinium derivatives of the formula III (III) in which A and R have the meanings defined above and in which X? represents the anion of a strong acid or of a halogen atom and formed as intermediate products. Compounds of the formula IV (IV) in which A and R have the meanings defined above, possessing the same structure as the starting material I but having an opposite configuration at the carbon atom (*), can be used as .beta.-blocking agents.
priorityDate 1982-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21908533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448212476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457501988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421412652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3839223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419898721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414857855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456148107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453059359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7311736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419644899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409046175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158617911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449537446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161706404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453915036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546506

Total number of triples: 81.